|
GB0906044D0
|
|
Nalmefene compositions and their therapeutic use
|
|
GB0906045D0
|
|
Nalmefene compositions and their therapeutic use
|
|
GB0906046D0
|
|
Nalmefene compositions and their therapeutic use
|
|
GB0906042D0
|
|
Nalmefene compositions and their therapeutic use
|
|
GB0906048D0
|
|
Novel compounds
|
|
GB0906047D0
|
|
Novel salts of nalmefene and their therapeutic use
|
|
GB0906043D0
|
|
Nalmefene compositions and their therapeutic use
|
|
GB0904043D0
|
|
The treatment of raynaud's phenomenon
|
|
GB0901246D0
|
|
Novel compounds
|
|
GB0901175D0
|
|
The treatment of skin aging
|
|
GB0821169D0
|
|
Novel compounds
|
|
WO2009047562A1
|
|
Methods and compositions for the treatment of pruritus
|
|
GB0817164D0
|
|
Crystalline forms
|
|
GB0814043D0
|
|
The treatment of skin disorders
|
|
GB0809319D0
|
|
The treatment of puritus
|
|
GB0809068D0
|
|
Compositions containing serine protease inhibitors
|
|
GB0808755D0
|
|
Use of opioid compounds in peripheral pain
|
|
GB0808750D0
|
|
Use of opioid compounds in scar formulation and acute wound care
|
|
GB0808754D0
|
|
Use of opiod compounds in peripheral pain
|
|
GB0808751D0
|
|
Topical compositions of opioid compound for use in wound healing
|
